ProShare Advisors LLC Has $14.19 Million Holdings in HCA Healthcare, Inc. $HCA

ProShare Advisors LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,403 shares of the company’s stock after acquiring an additional 1,755 shares during the quarter. ProShare Advisors LLC’s holdings in HCA Healthcare were worth $14,194,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. National Pension Service grew its holdings in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after purchasing an additional 17,531 shares in the last quarter. Savant Capital LLC lifted its position in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after purchasing an additional 1,246 shares during the period. Nordea Investment Management AB increased its holdings in HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after buying an additional 108,849 shares during the period. Sector Gamma AS lifted its holdings in shares of HCA Healthcare by 36.0% during the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after acquiring an additional 2,883 shares during the period. Finally, AlphaQuest LLC increased its stake in HCA Healthcare by 2,855.2% in the third quarter. AlphaQuest LLC now owns 5,999 shares of the company’s stock valued at $2,557,000 after acquiring an additional 5,796 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.9%

HCA opened at $397.08 on Thursday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The firm has a 50-day moving average price of $470.92 and a two-hundred day moving average price of $484.72. The stock has a market capitalization of $88.09 billion, a PE ratio of 13.65, a PEG ratio of 1.28 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period in the prior year, the business earned $6.45 EPS. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HCA shares. Wells Fargo & Company decreased their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Weiss Ratings lowered HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday. Leerink Partners dropped their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Mizuho upped their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Finally, Wall Street Zen lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $515.77.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA Healthcare received a consensus “Moderate Buy” rating from brokerages, suggesting Wall Street still sees upside despite recent volatility.
• Positive Sentiment: HCA Healthcare said colleagues volunteered more than 41,800 hours during its annual Days of Service initiative, reinforcing the company’s community and brand reputation. HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
• Positive Sentiment: At the RBC Capital Markets Global Healthcare Conference, HCA Healthcare’s presentation likely helped keep investors focused on the company’s strategy and fundamentals. HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
• Neutral Sentiment: Local articles about HCA Florida Lawnwood and other HCA facilities recognizing trauma staff and first responders are largely reputational and unlikely to materially affect near-term earnings. HCA Florida Lawnwood honors survivors, praises first responders and trauma staff HCA observes trauma awareness
• Neutral Sentiment: Reports that HCA hospitals are spending more than $10 million on employee pay raises signal ongoing labor-cost investment, but the market may view this as a cost headwind rather than a clear catalyst. Mission Hospital spends more than $10M on employee pay raises HCA hospital invests $10M to bump payroll
• Negative Sentiment: JPMorgan lowered its price target on HCA Healthcare from $535 to $490 and kept a neutral rating, which may be weighing on investor sentiment. JPMorgan adjusts price target on HCA Healthcare to 490 from 535, maintains neutral rating
• Negative Sentiment: The lower price target, combined with the stock trading well below recent highs, reinforces concerns that near-term upside may be limited.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.